Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased by 7% year-on-year, despite unprecedented uncertainty in the firm\u2019s target private equity markets. Demand for Humatica\u2019s organizational effectiveness and efficiency services grew as both new and long-standing clients turned to the firm for support in navigating an increasingly complex operating environment. Growth was broad-based, spanning Europe and North America.<\/p>\n
As private equity adapts to a slower deal environment and reduced capital inflows, asset managers are sharpening their focus on operational value creation to offset financial market and macro-economic headwinds. In this context, Humatica\u2019s tech-enabled org effectiveness and efficiency services have become important levers for unlocking portfolio company performance and value.<\/p>\n
During 1H 2025 Humatica strengthened its North American footprint with the appointment of two U.S.-based Operating Partners and a New York office. These steps enhance Humatica\u2019s ability to provide local support for U.S. and global clients in the Americas.<\/p>\n
The firm also scaled deployment of its AI-enabled altus behavioral benchmarking tools, applying them consistently across portfolios to set a new standard in assessing team performance and governance quality at scale.<\/p>\n
Humatica\u2019s outstanding achievements were recognized with multiple awards in the first half-year.
\nThe firm won both Actum\u2019s 2025 Value Creation Award as the best advisor for \u201cPeople & Organizational Strategy\u201d and Real Deals\u2019 Value Creation Adviser of The Year award \u2013 each for a second time. Additionally, Humatica was named as one of the top private equity advisory firms in the UK by Consulting.uk. These honors underscore the firm\u2019s growing reputation as a leader in delivering measurable results through organizational effectiveness and efficiency.<\/p>\n
Andros Payne, Managing Partner<\/strong> of Humatica, commented: Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased…<\/p>","protected":false},"author":4,"featured_media":9339,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[18,11],"tags":[],"class_list":["post-9338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-firm-news","category-news"],"acf":[],"yoast_head":"\n
\n<\/strong>“I’m very proud of the<\/em> Humatica<\/em> team that continues to deliver meaningful impact for our demanding private equity clients. What was once a specialist niche, has now become a mainstream requirement. After more than 20 years\u2019 focus on organizational efficiency and effectiveness, it\u2019s inspiring to see these levers at the top of the PE value creation agenda.”<\/em>
\n<\/em><\/p>","protected":false},"excerpt":{"rendered":"